LMA APPOINTS DAVID CHEW HENG CHING AS DEPUTY by jlhd32

VIEWS: 11 PAGES: 2

More Info
									FOR IMMEDIATE RELEASE




   LMA APPOINTS DAVID CHEW HENG CHING AS DEPUTY CHAIRMAN

    •   Mr Chew Heng Ching will hold the role in addition to his current position as Lead
        Independent Director


Singapore, 22 March 2011 – Mainboard-listed LMA International N.V. (“LMA”), the world’s
market leader in the laryngeal mask airway range of supraglottic airway management devices,
today announced it has appointed David Chew Heng Ching as Deputy Chairman. Mr Chew Heng
Ching will hold the role in addition to his current position as Lead Independent Director.


Mr Chew Heng Ching has been a Board member of LMA since May 2004. During his tenure, he
has been instrumental in helping the company cement its position as the global leader in
supraglottic airway management.


In addition to his dual role at LMA, Mr Chew Heng Ching is the founding Chairman of the
Singapore Institute of Directors. He is also a past Chairman of the Singapore International
Chamber of Commerce, Member of the Council on Corporate Disclosure and Governance,
Council Member of the Singapore Business Federation and Member of Parliament and Deputy
Speaker of the Singapore Parliament.


The role of Deputy Chairman was previously held by John Lim, who stepped down as a Director
at the end of 2010. The appointment was made during a Board meeting on 15th February 2011.


Executive Group Chairman, Trevor Swete, said: “I am delighted David has accepted the role of
Deputy Chairman. His decision further demonstrates his exceptional commitment to LMA, which
now stretches back nearly seven years. The knowledge, experience and understanding of the
business that David brings to the role is unparalleled and will be a significant asset to the firm
moving forward.”


                                                 - ENDS -
For media queries, please contact:
Henry Jakins, Tel: +65 6347 2326   HP: +65 9100 2983
Email: henry.jakins@edelman.com

Rachel Ho, Tel: +65 6494 1560        HP: +65 9648 6423
Email: rachel.ho@edelman.com

About LMA
LMA designs, manufactures, markets and distributes the innovative LMA™ laryngeal mask airway
range of supraglottic airway devices and LMA Atomization™ devices for pain free administration of
medication.

LMA™ laryngeal mask airway devices are used by physicians to allow respiration, provide ventilation
to, and support the airway of patients undergoing surgical procedures and life-saving interventions.
LMA Atomization™ devices allow healthcare professionals needle-stick free delivery of pain-free
medication to patients.

LMA is the global market leader for supraglottic airway devices, led by LMA Supreme™. LMA's
growth is driven by the development of innovative products, geographic expansion, and acquisition of
medical device technology to support anaesthetists and emergency healthcare professionals.

Incorporated in Curacao in 1998, LMA is listed on the Mainboard of the Singapore Exchange. LMA
has offices in Jersey, Channel Islands and Singapore, manufacturing facilities in Utah, USA and
Malaysia and subsidiaries with direct selling functions in the USA, Australia, New Zealand, Germany,
Italy and Singapore. For more information, visit www.lmaco.com.

								
To top